Mesoderm and definitive endoderm cell populations

Inactive Publication Date: 2006-01-05
MT SINAI SCHOOL OF MEDICINE
View PDF2 Cites 308 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0010] Antibodies that specifically recognize brach+ cells are also provided. The antibodies are useful, for example, for isolating mesendoderm and mesoderm cell populati

Problems solved by technology

While this segregation of developmental fates is well accepted in the field of developmental biology, to dat

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mesoderm and definitive endoderm cell populations
  • Mesoderm and definitive endoderm cell populations
  • Mesoderm and definitive endoderm cell populations

Examples

Experimental program
Comparison scheme
Effect test

example 1

Materials and Methods

[0077] ES cell growth and differentiation. ES cells were maintained on irradiated embryonic feeder cells in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 15% fetal calf serum (FCS), penicillin, streptomycin, LIF (1% conditioned medium) and 1.5×10−4 M monothioglycerol (MTG; Sigma). Two days prior to the onset of differentiation, cells were transferred on gelatinized plates in the same media. For the generation of EBs, ES cells were trypsinized and plated at various densities in differentiation cultures. Differentiation of EBs was carried out in 60 mm petri grade dishes in IMDM supplemented with 15% FCS, 2mM L-glutamine (Gibco / BRL), transferrin (200 ug / ml), 0.5mM ascorbic acid (Sigma), and 4.5×10−4 M MTG. Cultures were maintained in a humidified chamber in a 5% CO2 / air mixture at 37° C.

[0078] Serum Free Medium. Two different serum-free media were used in different aspects of the following examples: IIMD supplemented with Knockout SR (Gibco BRL) and S...

example 2

Generation of Targeted ES Cells

[0084] Under appropriate conditions in culture, embryonic stem (ES) cells will differentiate and form three dimensional colonies known as embryoid bodies (EBs) that contain developing cell populations from a broad spectrum of lineages. Smith (2001) Annu. Rev. Cell Dev. Biol. 17:435-62. Among these EB-derived populations, one can detect mesodermal derivatives including those of the hematopoietic, endothelial, cardiac muscle and skeletal muscle lineages.

[0085] In order to track the onset of mesoderm in EBs and to isolate cells representing this population, the green fluorescence protein (GFP) was targeted to the brachyury locus. The targeting construct contained the GFP cDNA, and artificial intron, SV40 poly(A) sequences and a loxP flanked neo cassette in the first exon and is depicted in FIG. 1. The thymidine kinase (TK) gene was included at the 3′ end of the targeting construct to select against random integration. The targeting vector was constructe...

example 3

Isolation of Brachyury+ Cells

[0093] To determine if brachyury+ cells could be isolated based on GFP expression, the GFP+ population from day 3.5 EBs was sorted and analyzed for expression of appropriate genes. FIG. 4A shows the gates used for the isolation of the GFP positive (2) and negative(1) populations. RT-PCR analysis revealed brachyury expression was restricted to the GFP+ fraction indicating that cell sorting based on GFP expression can be used to isolate brachyury+ cells. Flk-1, one of the earliest makers of hematopoietic and endothelial development, was present at higher levels in GFP+ that in the GFP− fraction indicating that it was expressed in at least a subpopulation of brachyury+ cells. In contrast to brachyury and Flk-1, Pax-6, a gene involved in early neuronal development [79,80], was expressed at higher levels in the GFP− fraction consistent with precursors of this lineage being brachyury negative. These cell-sorting studies indicate that expression of GFP under t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides cell populations that are enriched for mesendoderm and mesoderm, and cell populations that are enriched for endoderm. The cell populations of the invention are useful for generating cells for cell replacement therapy.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application is a continuation-in-part of U.S. application Ser. No. 10 / 514,759, the disclosure of which is incorporated herein by reference, which is a 371 of PCT / US03 / 15658 filed May. 19, 2003 and which application claims the benefit of U.S. application Ser. Nos. 60 / 381,617 filed May. 17, 2002 and 60 / 444,851 filed Feb. 4, 2003, the disclosures of which are incorporated herein by reference.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH [0002] This invention was made with government support under Grant Nos. 2RO1 HL 48834-09 and 2RO1 HL 65169-02 awarded by the National Institutes of Health. The government may have certain rights in the invention.BACKGROUND OF THE INVENTION [0003] During embryonic development, the tissues of the body are formed from three major cell populations: ectoderm, mesoderm and definitive endoderm. These cell populations, also known as primary germ cell layers, are formed through a process known as gastrulation...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/08C12N5/071C12N5/0735
CPCC12N5/0606C12N5/067C12N2500/99C12N5/0607C12N2501/385C12N2501/415C12N2506/02C12N2501/16A61P1/16A61P3/10A61P7/00A61P9/00A61P19/00A61P21/00C12N2500/90A01K67/00A01N1/02C12N5/0672C12N5/0603C12N2501/11C12N2501/115C12N2501/12C12N2501/148C12N2501/155C12N2501/40C12N2506/03
Inventor KELLER, GORDONGADUE, PAUL
Owner MT SINAI SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products